Temas and SAGA Successfully Validate RCL Technology With Titanium Recoveries of Up to 90.8% and Vanadium Recoveries of 97.4%

Successful Stage 1 Validation on SAGA's Titanium-Vanadium-Iron Mineralization is a Significant Step Toward Advancing Optimization and Commercial Deployment of Temas' Proprietary RCL ...
The Scientist

Sweat-Sensing Patch Tracks Parkinson’s Disease Drug Levels in Real-Time

The secret to better Parkinson’s disease treatment may sit in sweat. A new wearable patch for people with Parkinson’s disease can monitor their medication levels by sampling sweat from their ...
eLife

N6-Adenosine Methylation of a Single Site in SARS-CoV-2 5′-UTR Promotes Translation

This valuable study provides solid evidence that N6 methylation of A74 by METTL3 is required for efficient translation directed by the SARS-CoV-2 5′UTR in unin ...
The Scientist

The Scientist - Home

Earlier this year, the Lacks estate settled a lawsuit regarding a company’s profiting off of HeLa cells. The case serves as a reminder of the importance of proper ethics in human research.
marketindex

Temas and Saga RCL Validation- 90.8% Ti and 97.4% V Recovery

Read TIO's full ASX announcement titled "Temas and Saga RCL Validation- 90.8% Ti and 97.4% V Recovery" from 30 Jul 2026, on Market Index.